Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
Open-market buys, last 90 days
$52,276
in 13 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$52,276. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Equels Thomas K +$52K CEO & President 13 filings

Reading 64 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-12 CHEMEROW DAVID I. Director Conversion +25,000 28,441
2026-03-12 CHEMEROW DAVID I. Director Conversion · Series G Convertible Prefered Stock −25 0
2026-03-06 CHEMEROW DAVID I. Director Other acquisition · Series G Convertible Preferred Stock +25 $25,000.00 $625K 25
2026-03-06 CHEMEROW DAVID I. Director Other acquisition · Class G Warrants +50,000 50,000
2026-02-05 CHEMEROW DAVID I. Director Grant or award +2,800 $1.23 $3K 3,441
2025-03-14 CHEMEROW DAVID I. Director Grant or award +44,899 $0.12 $5K 64,189
2025-02-28 CHEMEROW DAVID I. Director Grant or award +19,290 $0.14 $3K 19,290

Page 1 of 1 · 7 trades